These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7460483)

  • 21. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine impairs clearance of antipyrine and desmethyldiazepam in the elderly.
    Divoll M; Greenblatt DJ; Abernethy DR; Shader RI
    J Am Geriatr Soc; 1982 Nov; 30(11):684-9. PubMed ID: 6813365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cimetidine does not reduce liver blood flow in cirrhosis.
    Henderson JM; Ibrahim SZ; Millikan WJ; Santi M; Warren WD
    Hepatology; 1983; 3(6):919-22. PubMed ID: 6629321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cimetidine dynamics after single intravenous doses.
    Pancorbo S; Bubrick MP; Chin TW; Miller KW; Onstad G
    Clin Pharmacol Ther; 1982 Jan; 31(1):83-8. PubMed ID: 7053310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.
    Pentikainen PJ; Neuvonen PJ; Tarpila S; Syvälahti E
    Br Med J; 1978 Sep; 2(6141):861-3. PubMed ID: 709096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
    J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R; Bodemar G; Norlander B
    Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.
    Pond SM; Tong T; Benowitz NL; Jacob P
    Aust N Z J Med; 1980 Oct; 10(5):515-9. PubMed ID: 6937164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine decreases theophylline clearance.
    Jackson JE; Powell JR; Wandell M; Bentley J; Dorr R
    Am Rev Respir Dis; 1981 Jun; 123(6):615-7. PubMed ID: 7023306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and elimination of nitrendipine in liver disease.
    Dylewicz P; Kirch W; Santos SR; Hutt HJ; Mönig H; Ohnhaus EE
    Eur J Clin Pharmacol; 1987; 32(6):563-8. PubMed ID: 3653225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine bioavailability after massive small bowel resection.
    Russo J; Watson WA; Nelson EW; Schentag JJ
    Clin Pharm; 1982; 1(6):558-61. PubMed ID: 7185547
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
    Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cimetidine in patients with liver disease.
    González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age and renal clearance of cimetidine.
    Drayer DE; Romankiewicz J; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1982 Jan; 31(1):45-50. PubMed ID: 7053303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cimetidine-a clinical and pharmacokinetic study.
    Webster J; Barber HE; Hawksworth GM; Jeffers TA; Petersen J; Petrie JC; Brunt PW; Mowat NA; Griffiths R
    Br J Clin Pharmacol; 1981 Apr; 11(4):333-8. PubMed ID: 7259925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of cimetidine in humans.
    Pedersen PV; Miller R
    J Pharm Sci; 1980 Apr; 69(4):394-8. PubMed ID: 7373532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of cimetidine on hepatic drug elimination in cirrhosis.
    Nelson DC; Avant GR; Speeg KV; Hoyumpa AM; Schenker S
    Hepatology; 1985; 5(2):305-9. PubMed ID: 3979962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.